Medicon Hellas S.A. MEDIC.AT Stock
Medicon Hellas S.A. Price Chart
Medicon Hellas S.A. MEDIC.AT Financial and Trading Overview
| Medicon Hellas S.A. stock price | 2.99 EUR |
| Previous Close | 3.6 EUR |
| Open | 3.6 EUR |
| Bid | 3.53 EUR x 50000 |
| Ask | 3.64 EUR x 20000 |
| Day's Range | 3.56 - 3.62 EUR |
| 52 Week Range | 2.7 - 4.15 EUR |
| Volume | 785 EUR |
| Avg. Volume | 1.43K EUR |
| Market Cap | 15.91M EUR |
| Beta (5Y Monthly) | 0.688888 |
| PE Ratio (TTM) | 21.052631 |
| EPS (TTM) | 0.17 EUR |
| Forward Dividend & Yield | 0.11 (3.16%) |
| Ex-Dividend Date | March 1, 2023 |
| 1y Target Est | N/A |
MEDIC.AT Valuation Measures
| Enterprise Value | 18.24M EUR |
| Trailing P/E | 21.052631 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.7185605 |
| Price/Book (mrq) | 1.0209869 |
| Enterprise Value/Revenue | 0.824 |
| Enterprise Value/EBITDA | 3.156 |
Trading Information
Medicon Hellas S.A. Stock Price History
| Beta (5Y Monthly) | 0.688888 |
| 52-Week Change | 22.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.15 EUR |
| 52 Week Low | 2.7 EUR |
| 50-Day Moving Average | 3.63 EUR |
| 200-Day Moving Average | 3.44 EUR |
MEDIC.AT Share Statistics
| Avg. Volume (3 month) | 1.43K EUR |
| Avg. Daily Volume (10-Days) | 3.32K EUR |
| Shares Outstanding | 4.42M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 44.74% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 22.03045:21.03045 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 12.59% |
| Operating Margin (ttm) | 20.66% |
| Gross Margin | 73.60% |
| EBITDA Margin | 26.10% |
Management Effectiveness
| Return on Assets (ttm) | 9.17% |
| Return on Equity (ttm) | 20.28% |
Income Statement
| Revenue (ttm) | 22.14M EUR |
| Revenue Per Share (ttm) | 5.01 EUR |
| Quarterly Revenue Growth (yoy) | 6.60% |
| Gross Profit (ttm) | 15.69M EUR |
| EBITDA | 5.78M EUR |
| Net Income Avi to Common (ttm) | 2.79M EUR |
| Diluted EPS (ttm) | 0.171 |
| Quarterly Earnings Growth (yoy) | -16.90% |
Balance Sheet
| Total Cash (mrq) | 10.18M EUR |
| Total Cash Per Share (mrq) | 2.3 EUR |
| Total Debt (mrq) | 12.06M EUR |
| Total Debt/Equity (mrq) | 74.21 EUR |
| Current Ratio (mrq) | 4.753 |
| Book Value Per Share (mrq) | 3.526 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.72M EUR |
| Levered Free Cash Flow (ttm) | 4.79M EUR |
Profile of Medicon Hellas S.A.
| Country | Greece |
| State | N/A |
| City | Gerakas |
| Address | Melitona 5-7 |
| ZIP | 153 44 |
| Phone | 30 210 66 06 000 |
| Website | https://www.mediconsa.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 180 |
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It also produces reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calibration materials, and tests. In addition, the company engages in the production of cosmetic and skin care products under the Miss Beaute brand name. Further, it develops and sells software for laboratory and medical applications, and supplies IT systems to healthcare providers. Additionally, the company remanufactures and resells chemistry, hematology, blood gas, and immunochemistry analyzers; and provides contract remanufacturing and diagnostics laboratory services. Medicon Hellas S.A. was founded in 1988 and is headquartered in Gerakas, Greece.
Q&A For Medicon Hellas S.A. Stock
What is a current MEDIC.AT stock price?
Medicon Hellas S.A. MEDIC.AT stock price today per share is 2.99 EUR.
How to purchase Medicon Hellas S.A. stock?
You can buy MEDIC.AT shares on the Athens exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medicon Hellas S.A.?
The stock symbol or ticker of Medicon Hellas S.A. is MEDIC.AT.
Which industry does the Medicon Hellas S.A. company belong to?
The Medicon Hellas S.A. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Medicon Hellas S.A. have in circulation?
The max supply of Medicon Hellas S.A. shares is 4.42M.
What is Medicon Hellas S.A. Price to Earnings Ratio (PE Ratio)?
Medicon Hellas S.A. PE Ratio is 17.48538000 now.
What was Medicon Hellas S.A. earnings per share over the trailing 12 months (TTM)?
Medicon Hellas S.A. EPS is 0.17 EUR over the trailing 12 months.
Which sector does the Medicon Hellas S.A. company belong to?
The Medicon Hellas S.A. sector is Healthcare.